Skip to main content

Table 6 OS and DFS for subgroup of patients with upper rectal cancer(tumor location≥7 cm from AV)

From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Group

Adjuvant chemotherapy Group (n = 87)

 

Adjuvant chemo-radiotherapy Group (n = 57)

P value

3-year

5-year

3-year

5-year

OS

94.22%

88.80%

 

98.15%

89.87%

0.619

DFS

89.66%

81.40%

 

85.71%

83.72%

0.953

  1. Abbreviations: adjuvant-chemo adjuvant chemotherapy, DFS disease-free survival, OS overall survival, AV anal verge